Acid Suppression and Adenocarcinoma of the Esophagus: Cause or Cure?

Schell, Thomas G.
October 2004
American Journal of Gastroenterology;Oct2004, Vol. 99 Issue 10, p1884
Academic Journal
In this issue El-Seraget al. present a retrospective study which shows that patients with Barrett's esophagus and no dysplasia who were prescribed PPIs had a lesser rate of developing dysplasia than patients who were not prescribed PPIs. Acid suppression has been proposed both as a cause and a cure for the“epidemic” of adenocarcinoma of the esophagus, which has been noted in the United States. The article and the current evidence related to acid suppression and adenocarcinoma of the esophagus are reviewed.(Am J Gastroenterol 2004;99:1884-1886)


Related Articles

  • Barrett's oesophagus: from metaplasia to dysplasia and cancer. Fléjou, J.-F. // Gut;Mar2005 Supplement 1, Vol. 54, pi6 

    Barrett's oesophagus is a premalignant condition that predisposes to the development oesophageal adenocarcinoma. It is detected on endoscopy and confirmed histologically by the presence in the lower oesophagus of a metaplastic mucosa, the so-called specialised epitheliurn, which resembles...

  • My approach to atypical melanocytic lesions.  // Journal of Clinical Pathology;Nov2004, Vol. 57 Issue 11, p1121 

    Histological assessment of melanocytic naevi constitutes a substantial proportion of a dermatopathologist's daily workload. Although they may be excised for cosmetic reasons, most lesions encountered are clinically atypical and are biopsied or excised to exclude melanoma. Although dysplastic...

  • Adenocarcinoma in Barrett Mucosa Treated by Endoscopic Mucosal Resection. Appelman, Henry D. // Archives of Pathology & Laboratory Medicine;Nov2009, Vol. 133 Issue 11, p1793 

    Adenocarcinoma and dysplasias are recognized complications of Barrett mucosa. In the past, the treatment for this carcinoma was esophagectomy. However, new techniques, including endoscopic mucosal resection, sometimes replace esophagectomy and are becoming standard procedures in clinical...

  • Adenocarcinoma complicating Barrett's esophagus: an analysis of cell proliferation. Matsumoto, Yutaka; Arai, Nobuyasu; Mieno, Hiroyoshi; Murakami, Kohtaro; Ishii, Keita; Mitomi, Hiroyuki // Journal of Gastroenterology;2001, Vol. 36 Issue 6, p410 

    In Japan, cases of Barrett's esophagus with concurrent adenocarcinoma are relatively rare. We report herein a case of long-segment Barrett's esophagus-associated adenocarcinoma in a 72-year-old Japanese man. The surgical specimen showed that an ulcerating tumor, measuring 5.5 × 3.9 cm, was...

  • Are screening and surveillance for Barrett's oesophagus really worthwhile? Sharma, P.; Sidorenko, E. I. // Gut;Mar2005 Supplement 1, Vol. 54, pi27 

    Oesophageal adenocarcinoma has a low incidence and still remains an uncommon cancer; however, it has been on the rise over the past 20 years. Barrett's oesophagus, a complication of gastro-oesophageal reflux disease, is the only known precursor of this adenocarcinoma. It can often be...

  • New developments in the endoscopic surveillance of Barrett's oesophagus. Bergman, J. J. G. H. M.; Tytgat, G. N. J. // Gut;Mar2005 Supplement 1, Vol. 54, pi38 

    Patients with a Barrett's oesophagus are at risk for developing an adenocarcinoma of the distal oesophagus. Therefore, many patients undergo endoscopic surveillance to detect dysplasia and/or cancer at an early and curable stage. However, early neoplastic lesions are difficult to identify with...

  • Evaluation and treatment of superficial esophageal cancer. DeMeester, Steven R. // Journal of Gastrointestinal Surgery;Feb2010 Supplement 1, Vol. 14, p94 

    Introduction: Adenocarcinoma of the esophagus is the fastest increasing cancer in the USA, and an increasing number of patients are identified with early-stage disease. The evaluation and treatment of these superficial cancers differs from local and regionally advanced...

  • Routine morphometrical analysis can improve reproducibility of dysplasia grade in Barrett's oesophagus surveillance biopsies. Baak, J.P.A.; ten Kate, F.J.W.; Offerhaus, G.J.A.; van Lanschot, J.J.; Meijer, G.A. // Journal of Clinical Pathology;Dec2002, Vol. 55 Issue 12, p910 

    Background: The grade of dysplasia found in Barrett's oesophagus surveillance biopsies is a major factor to determine follow up and treatment. However, it has been reported that the reproducibility of the grading system is not optimal. Aims: To compare routine and expert dysplasia grades in...

  • ANTAGONIST: Endoscopic surveillance of patients with Barrett's oesophagus. Playford, R.J. // Gut;Sep2002, Vol. 51 Issue 3, p314 

    Asserts that there is insufficient medical evidence to support the endoscopic surveillance of patients with Barrett's oesophagus. Impact of surveillance programs on the amount of oesophageal cancer in the community; Guidelines recommending surveillance; Need for more randomized trials showing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics